University of Patras
Μελέτη της προφυλακτικής δράσης της παρστατίνης έναντι της νεφροτοξικότητας των ιωδιούχων σκιαγραφικών μέσων κατά τη διάρκεια εξετάσεων με ψηφιακή αφαιρετική αγγειογραφία
Abstract
dc:descriptionIntroductionIodinated Contrast Media (CM) are today widely used in routine non-invasive or percutaneous invasive imaging examinations and therapeutic interventions. Unfortunately, use of CM is not free of complications with nephrotoxicity (Contrast-Induced nephropathy – CIN) being one of the most severe. Although numerous preventing and/or therapeutic strategies have been proposed and widely tested during recent years in the battle against CIN, none of them manage to show strong reliable evidence that can prevent CIN development.Parstatin is the N-terminal-41-amino-acid peptide cleaved by thrombin from the protease-activated receptor-1. Low doses of Parstatin are known to have a protective effect in the rat myocardium after ischemia/reperfusion injury. The primary hypothesis of our study was that Parstatin may exert a nephroprotective role against the development of CIN. To test this hypothesis we used a mammalian experimental CIN model.Materials and Methods:The first stage of the study involved the development of a reliable experimental model of nephrotoxicity after administration of iodinated contrast media. The model was developed and extensively evaluated in a series of New Zealand white rabbits. The next stage involved the systematic testing of the______________________________________________________________________ΕΚΤ | www.didaktorika.gr | 6protective effect of Parstatin. In this part the animals were divided into three sub-groups. A sub-group received the test substance (Parstatin) at a dose of 10mg/kg just 15 minutes before intravenous infusion of iodinated contrast medium. In the other two sub-groups Parstatin was administered at a dose of either subdivided by ten times (1mg/kg) or multiplied by ten times (100mg/kg) of the original. In this phase the control group was derived from the preliminary experiments of the first stage.As a threshold for the recognition of CIN development was the value of serum Creatinine equal to or more than 1,5 mg/dl 48 hours after injection of the CM. A representative sample of experimental animals was euthanized 48 hours after receiving the CM in order to perform histological examination and analysis.Results:The first part of the study included a total of 32 animals. In 7 of them only a simulation experiment was performed (group sham) to define baseline values of sCr. The mean serum Creatinine in this group was 0,90mg/dl (Cl:0,80-1,10). Following experiments showed that greater reproducibility of the model is achieved with injection rate of the contrast medium contrast between 2.5 έως 3,0 ml/min. Based on that the total contrast agent was administered between 28-35 minutes. In a total of 15 rabbits which were and the control group for the following experiments (control group) the mean sCr was 3,09 mg/dl (CI:2,40-4,00), while 86.7% of them developed clinically significant CIN.Regarding the results of the second part recognized that the maximum therapeutic effect of Parstatin is accomplished with a dose of 10mg/Kg. More specifically in the group of animals (Group P10, n=18) who received the abovementioned dose the mean sCr values 48 hours after administration of the CM was 1,01 mg/dl (CI:0,93-2,34) (Statistically significant difference compared with the control group, p=0,012). This therapeutic effect was eliminated when the dose was either multiplied or divided by 10. A significantly lower number of animals developed the CIN in the treatment group (Group P10) compared with the control group (27.8% vs. 86.7%, p<0.001).The histological results showed significantly less tubular necrosis in the group of animals treated with Parstatin compared to controls (13,13 Vs 26.60 in the control group, p = 0.0007).Conclusion:The test substance Parstatin successfully inhibits the development of contrast-induced nephrotoxicity in an in-vivo experimental model. The above result was verified both by laboratory measurements of serum Creatinine and after histological examination of kidney specimens. The above is a very optimistic message. Nevertheless, further studies are necessary to validate the protective role of Parstatin against contrast nephrotoxicity in both experimental and clinical settings
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Diamantopoulos, Athanasios
- Διαμαντόπουλος, Αθανάσιος
Subjects
dc:subject × 16- Παρστατίνη
- Νεφροτοξικότητα
- Ιωδιούχα σκιαγραφικά μέσα (ΙΣΜ)
- Αγγειογραφία
- Νεφροπάθεια οφειλόμενη σε σκιαγραφικά μέσα
- Parstatin
- Nephrotoxicity
- Lodine contrast media
- Angiography
- Contrast induced nephropathy
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Επιστήμες Υγείας
- Medical and Health Sciences
- Clinical Medicine
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29436